Co-Diagnostics Inc
NASDAQ:CODX

Watchlist Manager
Co-Diagnostics Inc Logo
Co-Diagnostics Inc
NASDAQ:CODX
Watchlist
Price: 1.01 USD -4.72% Market Closed
Market Cap: 32.2m USD
Have any thoughts about
Co-Diagnostics Inc?
Write Note

Wall Street
Price Targets

CODX Price Targets Summary
Co-Diagnostics Inc

Wall Street analysts forecast CODX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CODX is 1.53 USD with a low forecast of 1.52 USD and a high forecast of 1.58 USD.

Lowest
Price Target
1.52 USD
50% Upside
Average
Price Target
1.53 USD
51% Upside
Highest
Price Target
1.58 USD
56% Upside
Co-Diagnostics Inc Competitors:
Price Targets
OPTOMED
Optomed Oyj
45% Upside
6869
Sysmex Corp
3% Upside
STIL
Stille AB
30% Upside
SEDANA
Sedana Medical AB (publ)
105% Upside
DXCM
Dexcom Inc
34% Upside
PRN
Profound Medical Corp
73% Upside
CYC
Cyclopharm Ltd
100% Upside
688271
Shanghai United Imaging Healthcare Co Ltd
7% Upside

Revenue
Forecast

Revenue Estimate
Co-Diagnostics Inc

For the last 8 years the compound annual growth rate for Co-Diagnostics Inc's revenue is 126%. The projected CAGR for the next 2 years is -53%.

126%
Past Growth
-53%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Co-Diagnostics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat

Net Income
Forecast

Net Income Estimate
Co-Diagnostics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-16%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CODX's stock price target?
Price Target
1.53 USD

According to Wall Street analysts, the average 1-year price target for CODX is 1.53 USD with a low forecast of 1.52 USD and a high forecast of 1.58 USD.

What is Co-Diagnostics Inc's Revenue forecast?
Projected CAGR
-53%

For the last 8 years the compound annual growth rate for Co-Diagnostics Inc's revenue is 126%. The projected CAGR for the next 2 years is -53%.

Back to Top